TF and ovarian cancer: In Our study in which significant changes in serotransferrin sialylation were observed in multiple glycopeptides in ovarian cancer (Table 1), along with published reports suggesting serotransferrin could be a potential biomarker for ovarian cancer at both glycoprotein and glycopeptides level.